Zobrazeno 21 - 30
of 224
pro vyhledávání: '"Tetsuya Oguri"'
Autor:
Hirotsugu Ohkubo, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Nobutaka Kazawa, Ryuji Mikami, Akio Niimi
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152505 (2016)
Although several computer-aided computed tomography (CT) analysis methods have been reported to objectively assess the disease severity and progression of idiopathic pulmonary fibrosis (IPF), it is unclear which method is most practical. A universal
Externí odkaz:
https://doaj.org/article/17d5a6a1922647b5a3506e671ba4de67
Autor:
Hirotsugu Ohkubo, Yoshihiro Kanemitsu, Takehiro Uemura, Osamu Takakuwa, Masaya Takemura, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Nobukata Kazawa, Ryuji Mikami, Akio Niimi
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160231 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0152505.].
Externí odkaz:
https://doaj.org/article/3c6dd2b14002436989f2c978403b4a33
Autor:
Tomoko Tajiri, Motohiko Suzuki, Takeo Kutsuna, Hirono Nishiyama, Keima Ito, Norihisa Takeda, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Satoshi Fukuda, Takehiro Umemura, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura, Kosho Yoshikawa, Akio Niimi
Publikováno v:
Journal of Asthma and Allergy. 16:149-157
Tomoko Tajiri,1 Motohiko Suzuki,2,3 Takeo Kutsuna,4 Hirono Nishiyama,1 Keima Ito,1 Norihisa Takeda,1 Kensuke Fukumitsu,1 Yoshihiro Kanemitsu,1 Satoshi Fukuda,1 Takehiro Umemura,1 Hirotsugu Ohkubo,1 Ken Maeno,1 Yutaka Ito,1 Tetsuya Oguri,1 Masaya Take
Autor:
Nobuyuki Katakami, Toshihide Yokoyama, Satoshi Morita, Tatsuro Okamoto, Yoshiko Urata, Yoshihiro Hattori, Yasuo Iwamoto, Yuki Sato, Norihiko Ikeda, Toshiaki Takahashi, Haruko Daga, Tetsuya Oguri, Yasuhito Fujisaka, Kazumi Nishino, Shunichi Sugawara, Toshiyuki Kozuki, Masahide Oki, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Publikováno v:
International Journal of Clinical Oncology. 28:79-88
Since the overall survival (OS) of patients enrolled in the first clinical phase III trial (WJOG5108L) was not recorded owing to time constraints, the present study (WJOG5108LFS) with a longer follow-up (66.6 months) aimed to compare OS of those trea
Autor:
Hirotsugu, Ohkubo, Kohei, Fujita, Akiko, Nakano, Yuki, Amakusa, Yuta, Mori, Kensuke, Fukumitsu, Satoshi, Fukuda, Yoshihiro, Kanemitsu, Takehiro, Uemura, Tomoko, Tajiri, Ken, Maeno, Yutaka, Ito, Tetsuya, Oguri, Yoshiyuki, Ozawa, Takayuki, Murase, Akio, Niimi
Publikováno v:
Journal of Thoracic Disease. 14:4309-4318
The strength, assistance in walking, rising from a chair, climbing stairs, and falls questionnaire (SARC-F) is widely used for screening sarcopenia. We aimed to examine the association of SARC-F scores with the measurements of quality of life and act
Autor:
Yasuto, Yoneshima, Satoshi, Morita, Masahiko, Ando, Atsushi, Nakamura, Shunichiro, Iwasawa, Hiroshige, Yoshioka, Yasuhiro, Goto, Masafumi, Takeshita, Toshiyuki, Harada, Katsuya, Hirano, Tetsuya, Oguri, Masashi, Kondo, Satoru, Miura, Yukio, Hosomi, Terufumi, Kato, Toshio, Kubo, Junji, Kishimoto, Nobuyuki, Yamamoto, Yoichi, Nakanishi, Isamu, Okamoto
Publikováno v:
Clinical Lung Cancer. 23:585-592
Renal impairment can affect treatment tolerability and outcome in individuals with cancer. We aimed to assess the safety and efficacy of nab-paclitaxel for previously treated patients with advanced non-small cell lung cancer (NSCLC) and renal impairm
Autor:
Keima Ito, Tomoko Tajiri, Hirono Nishiyama, Ryota Kurokawa, Jenifer Maries Go Yap, Norihisa Takeda, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Satoshi Fukuda, Takehiro Uemura, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Masaya Takemura, Akio Niimi
Publikováno v:
Journal of Asthma and Allergy. 15:1561-1568
Keima Ito,1 Tomoko Tajiri,1 Hirono Nishiyama,1 Ryota Kurokawa,1 Jenifer Maries Go Yap,1 Norihisa Takeda,1 Kensuke Fukumitsu,1 Yoshihiro Kanemitsu,1 Satoshi Fukuda,1 Takehiro Uemura,1 Hirotsugu Ohkubo,1 Ken Maeno,1 Yutaka Ito,1 Tetsuya Oguri,1,2 Masay
Autor:
Toyohiro Hirai, Young Hak Kim, Hironori Yoshida, Yuichi Sakamori, Takashi Nomizo, Yuto Yasuda, Hitomi Ajimizu, Tetsuya Oguri, Yasushi Yoshimura, Koh Furugaki, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Funazo
Alectinib is used as a first-line treatment for anaplastic lymphoma kinase (ALK)-rearranged non–small cell lung cancer (NSCLC). Whereas other ALK inhibitors have been reported to be involved in resistance to ATP-binding cassette (ABC) transporters,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7a854b2d31d7a986a69421d9175fec
https://doi.org/10.1158/1535-7163.c.6542827
https://doi.org/10.1158/1535-7163.c.6542827
Autor:
Toyohiro Hirai, Young Hak Kim, Hironori Yoshida, Yuichi Sakamori, Takashi Nomizo, Yuto Yasuda, Hitomi Ajimizu, Tetsuya Oguri, Yasushi Yoshimura, Koh Furugaki, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Funazo
Figure S1. Schematic representation of the ABCC11 expression vector. Figure S2. Sequence analysis of the tyrosine kinase coding region of anaplastic lymphoma kinase (ALK). Figure S3. Cell viability assay of alectinib in H2228 and H2228-AR1S cells und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2799a23a2f7650adc680988fed098774
https://doi.org/10.1158/1535-7163.22520917.v1
https://doi.org/10.1158/1535-7163.22520917.v1
Autor:
Toyohiro Hirai, Young Hak Kim, Hironori Yoshida, Yuichi Sakamori, Takashi Nomizo, Yuto Yasuda, Hitomi Ajimizu, Tetsuya Oguri, Yasushi Yoshimura, Koh Furugaki, Hiroaki Ozasa, Takahiro Tsuji, Tomoko Funazo
ABCC11 sequence inserted into the vector
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d8581ccddebea21b5f62bf5ce7698f
https://doi.org/10.1158/1535-7163.22520914.v1
https://doi.org/10.1158/1535-7163.22520914.v1